|
Symbol
|
Z0AVGZ | RMALNV | RMAIAV | ACPCSQ | RMAZBV | ADSVTQ | RMA2MV | LDYILK | RMBOSV | RMBN0V | RSZRCH | RMBHMV | RMBN7V | RVZRCH | RVIRCH | RMAWKV | RMBIVV | RMAIFV | LOXSLK | RMBGGV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Barrier Reverse Convertible | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | LUKB Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | LUKB Softcallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti |
|
Sous-jacent
|
Galenica AG / Novartis AG / Roche PS / Sonova Hldg. AG | Galderma Group AG / Galenica AG / Ypsomed Hldg. AG | Galderma Group AG / Galenica AG / Straumann Hldg. AG | Galenica AG / Sonova Hldg. AG / Straumann Hldg. AG | Galenica AG / Sandoz Group AG / Straumann Hldg. AG | ABB N / Galenica AG / Sika AG | Galenica AG / Siegfried Hldg. AG / Straumann Hldg. AG | Galenica AG / UBS Group AG / VAT Group | Galenica AG / Medacta Group / Sandoz Group AG / Ypsomed Hldg. AG | Dottikon ES Holding AG / Ems-Chemie Hldg. AG / Galenica AG | Galenica AG / Lonza Group N / Straumann Hldg. AG | Galderma Group AG / Galenica AG / Sandoz Group AG / Straumann Hldg. AG | Beiersdorf AG / Galenica AG / Nestlé S.A. / Unilever N.V. | Bachem Hldg. AG / Galenica AG / Siegfried Hldg. AG | Galderma Group AG / Galenica AG / Sandoz Group AG | Ems-Chemie Hldg. AG / Galderma Group AG / Galenica AG | Galenica AG / Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | Galenica AG / Lonza Group N / Novartis AG / Sandoz Group AG | Galenica AG / Novartis AG / Roche PS | Galenica AG / Lonza Group N / Novartis AG / Ypsomed Hldg. AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
24.09.2026 | 07.12.2026 | 14.12.2026 | 16.12.2026 | 29.12.2026 | 05.02.2027 | 14.05.2027 | 22.12.2026 | 23.07.2027 | 07.02.2028 | 20.08.2027 | 03.09.2027 | 03.09.2027 | 20.09.2027 | 13.03.2028 | 04.10.2027 | 10.05.2027 | 29.11.2027 | 30.12.2027 | 24.01.2028 |
| Demande | 96,69 | 101,30 | 100,60 | 100,76 | 99,90 | 88,99 | 97,80 | 101,87 | 95,00 | 89,00 | 98,20 | 101,10 | 73,80 | 99,52 | 100,58 | 102,10 | 100,80 | 101,40 | 98,79 | 99,90 |
| Offre | 97,44 | 102,10 | 101,40 | 101,57 | 100,70 | - | 98,60 | 102,64 | 95,80 | 89,80 | 99,00 | 101,90 | - | 100,32 | 101,39 | 102,90 | 101,60 | 102,20 | 99,54 | 100,70 |